NYSE:CCM Concord Medical Services Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Concord Medical Services Hldg Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.06 0.00 (0.00 %) (As of 09/17/2020 12:00 AM ET) Add Compare Share Today's Range$2.06Now: $2.06▼$2.0650-Day Range$1.66MA: $1.94▼$2.1452-Week Range$1.13Now: $2.06▼$2.92Volume884 shsAverage Volume19,212 shsMarket Capitalization$89.33 millionP/E RatioN/ADividend YieldN/ABeta0.23 ProfileChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services. It also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions, as well as CT scanners and ECT scanners for diagnostic imaging. In addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, it offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as consulting services; sells medical equipment; and researches and develops medical technology. Additionally, the company establishes the Beijing Proton Medical Center that provides radiotherapy treatment options to cancer patients; and other specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2017, it operated a network of 44 cooperative centers based in 30 hospitals in 29 cities across 18 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Concord Medical Services. Previous Next 2.4 Community Rank Outperform VotesConcord Medical Services has received 197 “outperform” votes. (Add your “outperform” vote.)Underperform VotesConcord Medical Services has received 216 “underperform” votes. (Add your “underperform” vote.)Community SentimentConcord Medical Services has received 52.30% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Concord Medical Services and other stocks. Vote “Outperform” if you believe CCM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CCM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldConcord Medical Services does not currently pay a dividend.Dividend GrowthConcord Medical Services does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Concord Medical Services insiders have not sold or bought any company stock.Percentage Held by Insiders46.50% of the stock of Concord Medical Services is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.85% of the stock of Concord Medical Services is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Concord Medical Services are expected to grow in the coming year, from ($0.21) to ($0.14) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Concord Medical Services is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Concord Medical Services is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.81 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Offices & clinics of medical doctors Sub-IndustryN/A SectorMedical Current SymbolNYSE:CCM Previous Symbol CUSIPN/A CIK1472072 Webwww.concordmedical.com Phone86-10-5903-6688Debt Debt-to-Equity RatioN/A Current Ratio1.17 Quick Ratio1.17Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$28.49 million Price / Sales3.14 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-29.43Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees583 Outstanding Shares43,364,000Market Cap$89.33 million Next Earnings Date10/27/2020 (Estimated) OptionableNot Optionable $2.06 0.00 (0.00 %) (As of 09/17/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive CCM News and Ratings via Email Sign-up to receive the latest news and ratings for CCM and its competitors with MarketBeat's FREE daily newsletter. Concord Medical Services (NYSE:CCM) Frequently Asked Questions How has Concord Medical Services' stock been impacted by Coronavirus (COVID-19)? Concord Medical Services' stock was trading at $2.2198 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CCM shares have decreased by 7.2% and is now trading at $2.06. View which stocks have been most impacted by COVID-19. When is Concord Medical Services' next earnings date? Concord Medical Services is scheduled to release its next quarterly earnings announcement on Tuesday, October 27th 2020. View our earnings forecast for Concord Medical Services. How were Concord Medical Services' earnings last quarter? Concord Medical Services Hldg Ltd (NYSE:CCM) posted its earnings results on Wednesday, August, 24th. The company reported ($0.06) earnings per share for the quarter, missing the Zacks' consensus estimate of $0.21 by $0.27. The company had revenue of $18.93 million for the quarter. View Concord Medical Services' earnings history. Are investors shorting Concord Medical Services? Concord Medical Services saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 10,900 shares, an increase of 303.7% from the August 15th total of 2,700 shares. Based on an average daily trading volume, of 35,100 shares, the short-interest ratio is currently 0.3 days. Approximately 0.0% of the company's stock are short sold. View Concord Medical Services' Short Interest. Who are some of Concord Medical Services' key competitors? Some companies that are related to Concord Medical Services include Neuronetics (VMD), AngioDynamics (ANGO), DURECT (DRRX), Catalyst Pharmaceuticals (CPRX), Aeglea Bio Therapeutics (AGLE), HemaCare (HEMA), Repro Med Systems (KRMD), TFF Pharmaceuticals (TFFP), Merus (MRUS), Ergomed (ERGO), CytomX Therapeutics (CTMX), Amryt Pharma (AMYT), Oxford Immunotec Global (OXFD), AMAG Pharmaceuticals (AMAG) and Innate Pharma (IPHYF). View all competitors. What other stocks do shareholders of Concord Medical Services own? Based on aggregate information from My MarketBeat watchlists, some companies that other Concord Medical Services investors own include The Carlyle Group (CG), Hi-Crush Partners (HCLP), Fibrocell Science (FCSC), Gilead Sciences (GILD), Laurentian Bank of Canada (LB), Altria Group (MO), Domtar (UFS), Arbutus Biopharma (ABUS), Franklin Resources (BEN) and Biocept (BIOC). Who are Concord Medical Services' key executives? Concord Medical Services' management team includes the following people: Dr. Jianyu Yang, Chairman & CEO (Age 48)Mr. Yaw Kong Yap, CFO & Pres (Age 55)Ms. Xiao Fu, Chief Operating Officer (Age 52)Dr. Matthew D. Callister, Chief Medical Officer (Age 49)Ms. Xun Liu, Financial Controller What is Concord Medical Services' stock symbol? Concord Medical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "CCM." How do I buy shares of Concord Medical Services? Shares of CCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Concord Medical Services' stock price today? One share of CCM stock can currently be purchased for approximately $2.06. How big of a company is Concord Medical Services? Concord Medical Services has a market capitalization of $89.33 million and generates $28.49 million in revenue each year. The company earns $-44,100,000.00 in net income (profit) each year or ($1.83) on an earnings per share basis. Concord Medical Services employs 583 workers across the globe. What is Concord Medical Services' official website? The official website for Concord Medical Services is www.concordmedical.com. How can I contact Concord Medical Services? Concord Medical Services' mailing address is 18/F TOWER A GLOBAL TRADE CENTER 36 NORTH THIRD RING ROAD, BEIJING F4, 100013. The company can be reached via phone at 86-10-5903-6688 or via email at [email protected] This page was last updated on 9/18/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
